本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Evoke Pharma Inc.

6.99
+4.33162.78%
盘后7.040.0500+0.72%19:59 EDT
成交量:1.40亿
成交额:10.41亿
市值:1,043.51万
市盈率:-2.49
高:9.88
开:8.50
低:6.12
收:2.66
数据加载中...
2024/02/20

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

重要事件披露

Form 8-K - Current report
2024/02/08

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/07

SEC问询函

Form CORRESP - Correspondence
2024/02/07

SEC问询函

Form CORRESP - Correspondence
2024/01/17

SEC问询函

Form CORRESP - Correspondence
2024/01/17

SEC问询函

Form CORRESP - Correspondence
2024/01/16

SEC问询函

Form CORRESP - Correspondence
2024/01/16

SEC问询函

Form CORRESP - Correspondence
2024/01/11

SEC问询函

Form CORRESP - Correspondence
2024/01/11

SEC问询函

Form CORRESP - Correspondence
2024/01/11

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/05

SEC问询函

Form CORRESP - Correspondence
2024/01/05

SEC问询函

Form CORRESP - Correspondence
2024/01/04

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/19

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/15

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/29

重要事件披露

Form 8-K - Current report